NAD+ Decline and How to Restore It: A Complete Guide

NAD+ Decline and How to Restore It: A Complete Guide

By Sophie Chabloz | May 2026

NAD+ is the molecule your cells use to make energy, repair DNA, and run almost every metabolic process that keeps you alive. By the time you're 50, your levels sit at roughly half what they were at 20, and that decline tracks closely with much of what we call aging. This guide covers what NAD+ does, why it falls, which interventions have real evidence behind them, and how to tell whether yours are working. No miracles, no shortcuts, just the mechanism and the evidence.

In this article:

  • What NAD+ is and what it does in your cells

  • Why your NAD+ levels decline with age

  • The four real ways to raise NAD+

  • Why NMN became the front-runner among precursors

  • What "restored NAD+" means in practice

  • How to measure your levels and track progress

  • Where to go next

What NAD+ is and what it does in your cells

Nicotinamide adenine dinucleotide, abbreviated NAD+, is a coenzyme present in every living cell on the planet. It shuttles electrons during metabolism, donates ribose groups to the enzymes that repair damaged DNA, and fuels the sirtuin proteins that regulate cellular stress responses (Imai & Guarente, 2014).

Three of its jobs matter most for how you feel day to day.

Energy production

Your mitochondria use NAD+ to turn food into ATP, the molecule that powers everything from muscle contraction to thinking. When NAD+ runs low, mitochondrial output drops. You feel it as low-grade fatigue that rest doesn't fully lift, and as a longer recovery window after physical exertion.

DNA repair

Your cells accumulate roughly 100,000 DNA lesions a day from oxidation, UV exposure, and ordinary metabolism. The PARP enzymes that fix these lesions consume NAD+ as a substrate. Lower NAD+ means slower repair, and slower repair means more genomic damage accumulates over time. This is one of the recognised hallmarks of ageing (López-Otín et al., 2023).

Sirtuin signalling

The seven sirtuin proteins regulate everything from inflammation to mitochondrial biogenesis to circadian rhythm, and they all need NAD+ to function. Drop the NAD+ pool and the entire sirtuin network slows with it.

Why your NAD+ levels decline with age

NAD+ doesn't simply drain away over the years. Your body actively destroys more of it as you age, and three forces drive the decline.

The first is CD38. This enzyme, expressed on immune cells and other tissues, breaks down NAD+ as part of inflammatory signalling. CD38 expression climbs steadily after age 30, and it's now considered one of the dominant reasons NAD+ falls in older adults (Chini et al., 2020).

The second is reduced biosynthesis. The salvage pathway that recycles nicotinamide back into fresh NAD+ becomes less efficient with age, and its rate-limiting enzyme, NAMPT, shows lower activity in older tissue (Yoshino et al., 2018).

The third is rising demand. Chronic inflammation, oxidative stress, and accumulating DNA damage all pull harder on the NAD+ pool. The cellular accountant runs out of currency faster than the salvage pathway can replenish it.

By the time you're 50, intracellular NAD+ in muscle and liver tissue is typically 40 to 60 percent of what it was at 20. We cover the broader cellular picture at https://insights.avea-life.com/longevity/hallmarks-of-ageing/.

The four real ways to raise NAD+

There's a lot of noise about NAD+ restoration. Strip it back and four interventions have real support, each with its own evidence and trade-offs.

1. Oral precursors (NMN, NR, NAM, niacin)

These are the molecules your salvage pathway uses to rebuild NAD+. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two most studied, and both raise blood and tissue NAD+ in humans (Igarashi et al., 2022; Pencina et al., 2023). NMN, in capsule form, is now the most commonly used precursor in serious longevity protocols. NR is the precursor in AVEA's NAD+ Vitaliser, and it's the one to reach for in markets where NMN isn't available for sale. We cover the basics at https://insights.avea-life.com/longevity/what-is-nmn-and-how-does-it-work/.

2. NAD+ IV infusions

Direct intravenous NAD+ raises blood levels quickly. The catch is that extracellular NAD+ doesn't enter cells efficiently in its native form. Most of it is broken down to nicotinamide before uptake, then reassembled inside the cell through the same salvage pathway an oral precursor would feed. IV protocols are also expensive and clinic-administered, commonly running into the hundreds of euros per session. The full comparison is at https://insights.avea-life.com/longevity/nad-injections-vs-nad-supplement-which-supports-lasting-cellular-health-better/.

3. CD38 inhibition

If CD38 is destroying your NAD+, slowing it down raises levels indirectly. Apigenin, the flavonoid found in parsley and chamomile, is a natural CD38 inhibitor with reasonable preclinical evidence (Escande et al., 2013). It's why apigenin features in second-generation longevity formulations like the AVEA Booster, which pairs it with other NAD+ actives and is taken alongside NMN.

4. Lifestyle

Caloric restriction, time-restricted eating, vigorous exercise, and consistent sleep all upregulate NAMPT and the salvage pathway. None of these will double your NAD+ on their own, but without them no supplement strategy compounds the way it should.

Why NMN became the front-runner among precursors

NMN earned its position among NAD+ precursors for three reasons.

First, it sits one biochemical step from NAD+ itself. The NMNAT enzymes convert NMN directly into NAD+ inside the cell, while other precursors take more steps and lose more along the way.

Second, the human evidence is now substantial. Across roughly a dozen randomised trials, oral NMN consistently raises blood NAD+ and shows measurable functional benefits: better insulin sensitivity in postmenopausal women with prediabetes (Yoshino et al., 2021), maintained walking speed and improved sleep quality in older adults (Morifuji et al., 2024), and modest gains in muscle force. The effect sizes are real but moderate, which is what you'd expect from a cellular cofactor rather than a drug. Anyone selling you "transformational" results from a precursor is overstating the data.

Third, manufacturing has matured. Until recently, most NMN sold online was synthesised cheaply in unregulated facilities, and a 2021 analysis found that more than half of the products tested contained essentially zero NMN. The market has since split into two tiers: contract-manufactured NMN of unknown purity, and pharmaceutical-grade enzymatic NMN produced under GMP conditions. The AVEA NMN supplement uses Longevir™, the only NMN currently manufactured in Europe (Borealis Pharma, the Netherlands), with enzymatic synthesis verified at greater than 99 percent purity.

What "restored NAD+" means in practice

This is where a lot of marketing quietly misleads people. Restoring NAD+ is not the same as reversing aging. It brings one important cofactor back closer to youthful levels, which lifts a metabolic ceiling, but it doesn't undo decades of cellular wear.

What you can reasonably expect from a quality NMN protocol over 30 to 90 days:

A measurable rise in blood and intracellular NAD+. In an internal AVEA case study, a 43-year-old man roughly doubled his intracellular NAD+ over three weeks on daily NMN, measured with AVEA's dried blood spot test. In our customer survey of 280 NMN users, 80 percent reported noticeably better energy and focus within 30 days, and 73 percent reported better sleep.

Subtle but real changes in baseline energy and recovery. The shift most people describe is that their worst days get less bad, rather than their best days getting dramatically better.

Slower, harder-to-feel changes in metabolic and inflammatory markers, the kind that show up on bloodwork long before they show up in the mirror.

What you should not expect: rapid weight loss, dramatic skin transformation, or the wholesale "feeling 20 again" that some marketing promises. Those claims run past the evidence, and they erode trust in the category.

How to measure your levels and track progress

You don't strictly need to test. But if you're putting real money and time into a protocol, a baseline reading is what separates tracking from guessing.

The two relevant measures are circulating (plasma) NAD+ and intracellular NAD+. Intracellular is the more meaningful of the two, because that's where NAD+ does its work, but it's harder to assay. Dried blood spot tests measure intracellular NAD+ in red blood cells and have become the practical standard for at-home tracking over time.

The AVEA NAD+ Test Kit uses a dried blood spot method. You take a baseline reading, start your protocol, then retest at 8 to 12 weeks. The result tells you whether your absorption, dosing, and pathway integrity are doing what they should. If NAD+ hasn't moved, something is off, usually purity, dose, or methylation capacity, and knowing that is worth more than another month of waiting.

Where to go next

If this was your first deep look at NAD+, the natural next reads are "What is NAD+ and why it declines with age" for the underlying biochemistry, "NMN supplements: how they work, who they're for" for a closer look at the precursor most people start with, and "NMN dosage: 250 mg vs 500 mg vs higher amounts" if you're already deciding what to take.

To widen the lens beyond NAD+, the articles on cellular energy and the 12 hallmarks of aging set the broader context that NAD+ sits inside.

Related reading from AVEA insights

Leave a Reply

Your email address will not be published. Required fields are marked *